SELUMETINIB
Background and Date of Approval
Selumetinib received FDA approval on April 10, 2020, for treatment of paediatric patients 2 years of age and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.
Uses
Selumetinib is primarily used in the treatment of specific types of cancer, particularly in patients with mutations in the BRAF gene. It is employed for conditions such as neurofibromatosis type 1 (NF1) and certain pediatric brain tumors.
How is it administered?
Selumetinib is primarily administered orally, typically in the form of capsules. The healthcare provider will determine the dosage and duration of treatment based on the specific infection and individual factors.
Side Effects
Selumetinib may result in various side effects, including cardiac issues, eye problems like changes in vision, skin reactions such as rash and dryness, gastrointestinal disturbances like nausea and diarrhea, the potential impact on liver function, musculoskeletal problems like muscle pain, hypertension, increased risk of bleeding, and potential harm to a developing fetus.
Warnings
Selumetinib might cause heart-related problems. Some patients may experience changes in vision, such as blurred vision or difficulty focusing. Skin-related side effects like rash, dry skin, or hair color or texture changes can occur. Some patients may experience increased blood pressure.
Precautions
It is essential to monitor heart function regularly while taking Selumetinib. Eye exams before and during treatment are often recommended. Managing these symptoms through diet and medications may be necessary. Regular liver function tests are typically recommended. Monitoring blood pressure regularly is important.
Word of Advice
Cardiac function requires regular monitoring, including electrocardiograms and cardiac assessments, owing to potential cardiac side effects during Selumetinib treatment. Periodic ophthalmological examinations are advised as the medication may cause vision changes or retinal vein occlusion. Patients should be monitored for signs of interstitial lung disease or respiratory difficulties. Liver function monitoring via blood tests is essential due to risk of elevated liver enzymes or hepatic damage. Live vaccines are generally contraindicated during treatment owing to potential complications. Regular monitoring may be necessary for patients with pre-existing endocrine conditions. Patients should discuss concurrent medications with their healthcare professional, including over-the-counter drugs, herbal supplements, and vitamins, to identify potential interactions.
References
MARC R THEORET, Food and Drug Administration (FDA),[Revised on April 2020] [ Accessed on 15th Nov 2023] AstraZeneca UK Limited, Electronic medicines compendium (EMC), [ Revised on 15 Mar 2023] [ Accessed on 15th Nov 2023], https://www.medicines.org.uk/emc/product/12948/pil#gref
Frequently Asked Questions
What are the common side effects of Selumetinib?
Common side effects of Selumetinib may include nausea, vomiting, diarrhea, fatigue, skin rash, and swelling.
Are there any dietary restrictions while taking Selumetinib?
No specific dietary restrictions are known while taking Selumetinib, but following a balanced diet is advisable unless otherwise instructed by a healthcare professional.
What should I do if I miss a dose of Selumetinib?
If you miss a dose of Selumetinib, take it as soon as you remember unless it's close to the time for the next scheduled dose. Do not double the dose to catch up. Contact your healthcare provider for guidance.
How long does it take for Selumetinib to work?
The response to Selumetinib can vary among individuals. Some may experience a reduction in tumor size or symptoms within weeks to months, while others may take longer to see noticeable effects.
Can Selumetinib cure cancer?
Selumetinib is a treatment that aims to control the growth and spread of cancer cells. It may shrink tumors and improve symptoms, but its ability to completely cure cancer varies based on individual circumstances and the type and stage of cancer.
How often will I need to undergo medical tests while taking Selumetinib?
The frequency of medical tests for Selumetinib, such as blood tests or imaging studies, will depend on individual factors and your healthcare provider's recommendations. Monitoring is often necessary to manage potential side effects and track treatment progress.